COVID-10 Clinical Trial Begins

A Phase 1 clinical trial being is going to begin to evaluate an investigational vaccine designed to protect against COVID-19 at the Kaiser Permanente Washington Health Research Institute (KPWHRI) https://www.kpwashingtonresearch.org in Seattle. Lisa A. Jackson, MD, Senior Investigator at KPWHR is leading the clinical trial. (more…)

Share Button

CLS Offers Free Services to Labs

Coriell Life Sciences (CLS) https://www.coriell.com a provider of molecular test interpretation and reporting is offering their coronavirus analysis and reporting services to laboratories in the U.S. at no cost during the public health crisis. (more…)

Share Button

PCORI Approves Up to $195 Million

The Patient-Centered Outcomes Research Institute’s (PCORI) https://www,pcori.org, an independent nonprofit nongovernmental organization primarily focused on CER, has approved up to $195 million for upcoming funding opportunities plus $16 million for research to compare the most effective ways to treat a range of health conditions that impose high burdens on patients, families, and the healthcare system. (more…)

Share Button

VA & DOD Studying mTBI

The VA https://www.research.va.gov and the Department of Defense https://www.defense.mil launched an ambitious project called the “Long-term Impact of Military Relevant Brain Injury Consortium (LIMBIC) to study mild Traumatic Brain Injuries (mild TBI). (more…)

Share Button

Premier’s Actions on COVID-19

Credit Suisse https://www.credit-suisse.com recently checked with Premier Inc. (PINC) https://www.premierinc.com to discuss the implications for their business and day-to-day operation amid the CoVID-19 Outbreak. According to Premier management, hospitals are coping with shortages in the supply chain, bit the supply chain is getting strained, so Premier has been helping member hospitals cope with the situation at hand for the last 2-3 weeks. (more…)

Share Button

CDC’s Grant Forecast for BRFSS

CDC posted a forecast for a Funding Opportunity Notice  on February 3, 2020  on https://www.grants.gov that funds will be available for FY 2020 to implement their “Behavioral Risk Factor Surveillance System (BRFSS): Impact in Population Health”. (more…)

Share Button

NIH Launches Data Portal for PD

The “Accelerating Medicines Partnership (AMP) program for Parkinson’s disease (PD) is a joint venture between NIH, FDA, industry partners (Celgene, GSK, Pfizer, Sanofi, and Verily),  and one non-profit organization (The Michael J. Fox Foundation for Parkinson’s Research MHFF) managed through the Foundations for NIH (FNIH). (more…)

Share Button